Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$128M |
| 2 |
FedEx
FDX
|
+$120M |
| 3 |
Peloton Interactive
PTON
|
+$97.8M |
| 4 |
Newmont
NEM
|
+$78.9M |
| 5 |
Infosys
INFY
|
+$78.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$291M |
| 3 |
Apple
AAPL
|
+$261M |
| 4 |
Microsoft
MSFT
|
+$240M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.85% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 14.74% |
| 4 | Consumer Staples | 10.36% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
DexCom
DXCM
$34.4B
| $5.55M | 0.01% |
60,976
-4,488
| -7% | -$401K |
|
|
VAR
752
DELISTED
Varian Medical Systems, Inc.
VAR
| $5.53M | 0.01% |
31,621
-46,168
| -59% | -$8.01M |
|
753
Avis
CAR
$5.19B
| $5.53M | 0.01% |
148,522
-289,474
| -66% | -$10.2M |
|
754
Johnson Outdoors
JOUT
$491M
| $5.51M | 0.01% |
48,913
-10,987
| -18% | -$999K |
|
755
Dycom Industries
DY
$11.4B
| $5.5M | 0.01% |
74,174
+69,296
| +1,421% | +$4.78M |
|
756
XPeng
XPEV
$10.7B
| $5.5M | 0.01% |
+128,429
| New | +$4.72M |
|
757
Wintrust Financial
WTFC
$10.3B
| $5.46M | 0.01% |
89,839
-167,651
| -65% | -$9.02M |
|
758
Keysight
KEYS
$52.9B
| $5.45M | 0.01% |
41,603
-40,485
| -49% | -$4.66M |
|
759
Nucor
NUE
$55.5B
| $5.44M | 0.01% |
103,969
-49,370
| -32% | -$2.55M |
|
760
Toro Company
TTC
$9.47B
| $5.43M | 0.01% |
57,526
+7,129
| +14% | +$630K |
|
761
DNOW Inc
DNOW
$2.8B
| $5.42M | 0.01% |
755,412
-366,841
| -33% | -$2.06M |
|
|
SGI
762
Somnigroup International
SGI
$13.5B
| $5.42M | 0.01% |
200,635
-287,273
| -59% | -$7.01M |
|
763
Denali Therapeutics
DNLI
$3.87B
| $5.35M | 0.01% |
63,867
+12,620
| +25% | +$763K |
|
764
NOV
NOV
$7.04B
| $5.34M | 0.01% |
389,141
+188,646
| +94% | +$2.13M |
|
|
EQC
765
DELISTED
Equity Commonwealth
EQC
| $5.33M | 0.01% |
197,662
+133,420
| +208% | +$3.56M |
|
766
FormFactor
FORM
$8.43B
| $5.31M | 0.01% |
123,340
-57,320
| -32% | -$2.07M |
|
767
Tetra Tech
TTEK
$9.44B
| $5.28M | 0.01% |
229,965
-235,170
| -51% | -$5.3M |
|
768
Ultragenyx Pharmaceutical
RARE
$2.54B
| $5.26M | 0.01% |
38,018
+8,959
| +31% | +$1.06M |
|
769
Fidelity National Information Services
FIS
$21.4B
| $5.22M | 0.01% |
37,024
+4,049
| +12% | +$578K |
|
770
NETSCOUT
NTCT
$2.75B
| $5.22M | 0.01% |
191,145
-124,609
| -39% | -$2.98M |
|
771
WaFd
WAFD
$2.69B
| $5.19M | 0.01% |
202,771
+114,036
| +129% | +$2.71M |
|
772
Bank of Hawaii
BOH
$3.03B
| $5.18M | 0.01% |
67,938
-17,670
| -21% | -$1.21M |
|
773
Norfolk Southern
NSC
$79.3B
| $5.18M | 0.01% |
21,975
+12,095
| +122% | +$2.75M |
|
774
Boise Cascade
BCC
$2.87B
| $5.18M | 0.01% |
108,420
-42,532
| -28% | -$1.85M |
|
775
PTC
PTC
$16.7B
| $5.17M | 0.01% |
43,240
-46,040
| -52% | -$4.58M |
|
Similar funds
Cliff Asness's Q4 2020 Portfolio in Review
As of Q4 2020, Cliff Asness held 2,327 positions worth $56.4B, down 4.7% from $59.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cliff Asness withdrew a net $9.06B in Q4 2020, closing 151 positions and reducing 1,279 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $291M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cliff Asness opened a new position in Peloton Interactive worth $122M.
- Cliff Asness's largest Q4 2020 buy was Peloton Interactive: 803,242 shares worth $122M.
- Cliff Asness added most to Zoom in Q4 2020, an estimated $128M increase.
- Cliff Asness's biggest Q4 2020 reduction was Biogen, cutting an estimated $309M.
- Cliff Asness fully exited iShares Core S&P 500 ETF in Q4 2020, selling an estimated $291M.
- Cliff Asness's ten largest holdings make up 19% of its $56.4B portfolio in Q4 2020.
- Cliff Asness opened 157 new positions and closed 151 in Q4 2020.
- Cliff Asness's portfolio value fell 4.7% quarter-over-quarter to $56.4B.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.